Rheumo, Golfer(pathetic), Caravaggisti, Prof School of Medicine Griffith University, A/Prof Univ. of Qld, Director Rheumatology Research Unit Sunshine Coast,
Joined December 2011
- Tweets 1,076
- Following 56
- Followers 967
- Likes 36
93 Photos and videos
May 26
OP002 (2026)
ANIFROLUMAB TREATMENT IN PATIENTS WITH SJÖGREN’S DISEASE: EFFICACY AND SAFETY ASSESSMENT IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE IIA PROOF-OF-MECHANISM TRIAL (ANISE-II) anifrolumab works in SjD - high interferon signature works the best? #EULAR2026
1
1
195
7 Jun 2025
POS0773 (2025)
LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS OR PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB: LONG-TERM RESULTS FROM PHASE 2B/3 TRIALS
- 5000 pt yrs AxSpA & PsA - low uveitis rates - bime or selection? #bimekizumab #uveitis #AxSpA #PsA
1
216
7 Jun 2025
POS0109 (2025)
COMPARATIVE PERSISTENCE AND EFFECTIVENESS OF IXEKIZUMAB VERSUS OTHER b/tsDMARD CLASSES IN REAL-WORLD PsA TREATMENT: 12-MONTH RESULTS FROM THE PRO-SPIRIT STUDY - a practical comparison #ixekizumab #TNF #IL23i
1
200
7 Jun 2025
OP0096 (2025)
Sonelokimab, IL-17A- & IL-17F- Nanobody, outcomes PsA: Ph 2 ARGO trial
SLK 60mg n=41 SLK 120mg n=43 ADA ref n=42
MDA(n/%) 25 (61.0). 22 (51.2). 19 (45.2)
nanobody effective- question is same or better? #IL17 #nanobody #sonelokimab
190
22 May 2025
Hence the Emery editorial in Rheumatology journal - biosimilar Toci from day 1 #RA #Tocilizumab #MTX
199
13 May 2025
Zepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ... medpagetoday.com/endocrinolo… need the best for IMIDs
128
10 May 2025
BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection | New England Journal of Medicine nejm.org/doi/full/10.1056/NE… Doesnt protect.
105
10 May 2025
Varenna, M., Zucchi, F., Di Taranto, R. et al. Osteoclast in CRPS: an alleged guilty fully acquitted. Osteoporos Int 36, 737–740 (2025). doi.org/10.1007/s00198-025-0… its not the Osteoclast! but perhaps dependent on acute vs chronic changes
109
5 May 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis | New England Journal of Medicine nejm.org/doi/full/10.1056/NE… FDA approved now #GCA #Upadcitinib
3
156
5 May 2025
A new toxicity syndrome in patients with autoimmune disease treated with CAR T-cell therapy - The Lancet Rheumatology thelancet.com/journals/lanrh… We need comparative studies! #CAR-T #LICATS
3
5
351
7 Mar 2025
i have been using once a month risedronate post denosumab cessation - here zoledronate useful alternative link.springer.com/article/10…
2
5
381
6 Mar 2025
Human Papillomavirus Vaccination and Actinic Keratosis Burden jamanetwork.com/journals/jam… affects many of our patients MTX, TNFs, JAKs QLD sun ! #IMID #HPVvax #RheumNow
134
6 Feb 2025
CD4 T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53 | New England Journal of Medicine nejm.org/doi/full/10.1056/NE… not seen in IMID CAR-T cell therapy yet but instructive nevertheless
1
3
245